Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

ELL Inhibitors

ELL inhibitors belong to a significant chemical class characterized by their specific interaction with a pivotal cellular process. These inhibitors are renowned for their ability to modulate gene expression by targeting a specific transcription elongation factor. In cellular processes involving gene expression, transcription elongation is a crucial step where RNA polymerase progresses along the DNA template, synthesizing the complementary RNA strand. ELL inhibitors exert their effects by binding to the ELL protein, a key component of the super elongation complex (SEC), which plays a pivotal role in promoting RNA polymerase II's transcriptional elongation. Through this interaction, ELL inhibitors subtly influence the dynamics of RNA polymerase progression, leading to nuanced alterations in the transcriptional profile of target genes. Structurally, ELL inhibitors encompass a diverse array of chemical entities, each displaying unique binding affinities and selectivity profiles for the ELL protein. Their chemical compositions vary widely, incorporating aromatic rings, heterocyclic moieties, and various functional groups, thereby enabling them to establish intricate interactions with the protein's active site. This interaction typically interferes with the normal progression of transcription, occasionally leading to premature transcriptional termination or other regulatory outcomes. Researchers have extensively explored the mechanisms by which ELL inhibitors affect transcription elongation, unraveling the complex interplay between the SEC, ELL protein, and RNA polymerase. Studies elucidating the three-dimensional structures of ELL inhibitors bound to the ELL protein have provided valuable insights into the molecular basis of their inhibitory activity. These investigations have facilitated the rational design of novel ELL inhibitors with enhanced potency and specificity, holding promise for further advancements in our understanding of gene regulation and potential applications in diverse fields. In conclusion, ELL inhibitors represent a noteworthy class of chemical compounds that exhibit the unique capability to modulate transcription elongation through their interaction with the ELL protein.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Everolimus is an mTOR inhibitor studied in the research of various cancers, including renal cell carcinoma and certain types of breast cancer.

Ridaforolimus

572924-54-0sc-212783
5 mg
$248.00
1
(0)

Ridaforolimus is an investigational mTOR inhibitor being studied for its potential in various types of cancer.

BKM120

944396-07-0sc-364437
sc-364437A
sc-364437B
sc-364437C
5 mg
10 mg
25 mg
50 mg
$173.00
$230.00
$275.00
$332.00
9
(0)

BKM120 is a PI3K inhibitor that has been studied for its potential in breast cancer and other solid tumors.

CAL-101

870281-82-6sc-364453
10 mg
$189.00
4
(1)

CAL-101 is a PI3K-delta inhibitor that has been studied in hematologic malignancies.

Saracatinib

379231-04-6sc-364607
sc-364607A
10 mg
200 mg
$113.00
$1035.00
7
(1)

Saracatinib is a dual PI3K/mTOR inhibitor that has been evaluated for its anticancer effects.